Literature DB >> 12007961

Measurements and clinical consequences of prostate motion during a radiotherapy fraction.

Aart J Nederveen1, Uulke A van der Heide, Homan Dehnad, R Jeroen A van Moorselaar, Pieter Hofman, Jan J W Lagendijk.   

Abstract

PURPOSE: Here we study the magnitude of prostate motion during the delivery of a radiotherapy fraction. These motions have clinical consequences for on-line position verification and the choice of margins around the target volume. METHODS AND MATERIALS: We studied the motion of the prostate for 10 patients during 251 radiotherapy treatment fractions by assessing the position of implanted gold markers. Gold markers of 1 mm diameter and 5 mm length were implanted in the prostate before the start of the radiotherapy. We obtained movies during each fraction using an a-Si flat-panel imager. The markers could be detected in separate frames using a marker extraction kernel.
RESULTS: Marker displacements as large as 9.5 mm were detected in one fraction. The motion of the prostate is greatest in the caudal-cranial and the anterior-posterior directions. Within a time window of 2 to 3 min, deviations from the initial marker position, averaged over all patients, are 0.3 +/- 0.5 mm and -0.4 +/- 0.7 mm in the anterior-posterior and caudal-cranial directions, respectively.
CONCLUSIONS: It appeared that on average, the intrafraction prostate motions did not result in margins larger than 1 mm, provided that the position verification is performed at time intervals of 2 to 3 min. Only for some patients performing more frequent position verification or adding extra margins of 2 to 3 mm is required to account for intrafraction prostate motions.

Entities:  

Mesh:

Year:  2002        PMID: 12007961     DOI: 10.1016/s0360-3016(01)02823-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  30 in total

Review 1.  Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

Authors:  Alan Pollack; Alex Hanlon; Eric M Horwitz; Steven Feigenberg; Robert G Uzzo; Robert A Price
Journal:  World J Urol       Date:  2003-09-05       Impact factor: 4.226

2.  The observed variance between predicted and measured radiation dose in breast and prostate patients utilizing an in vivo dosimeter.

Authors:  Charles W Scarantino; Bradley R Prestidge; Mitchel S Anscher; Carolyn R Ferree; William T Kearns; Robert D Black; Natasha G Bolick; Gloria P Beyer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

3.  Prostate intrafraction motion evaluation using kV fluoroscopy during treatment delivery: a feasibility and accuracy study.

Authors:  Justus Adamson; Qiuwen Wu
Journal:  Med Phys       Date:  2008-05       Impact factor: 4.071

4.  Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy.

Authors:  Jeffrey R Olsen; Parag J Parikh; Michael Watts; Camille E Noel; Kenneth W Baker; Lakshmi Santanam; Jeff M Michalski
Journal:  Radiother Oncol       Date:  2012-07-17       Impact factor: 6.280

5.  Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.

Authors:  Kiyonao Nakamura; Takashi Mizowaki; Haruo Inokuchi; Itaru Ikeda; Takahiro Inoue; Tomomi Kamba; Osamu Ogawa; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2017-07-29       Impact factor: 3.402

6.  Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume?

Authors:  Vivek Verma; Shifeng Chen; Sumin Zhou; Charles A Enke; Andrew O Wahl
Journal:  Strahlenther Onkol       Date:  2016-12-01       Impact factor: 3.621

7.  Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers.

Authors:  David Skarsgard; Pat Cadman; Ali El-Gayed; Robert Pearcey; Patricia Tai; Nadeem Pervez; Jackson Wu
Journal:  Radiat Oncol       Date:  2010-06-10       Impact factor: 3.481

8.  Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity.

Authors:  Sonia Drozdz; Michael Schwedas; Henning Salz; Susan Foller; Thomas G Wendt
Journal:  Strahlenther Onkol       Date:  2016-01-07       Impact factor: 3.621

9.  Respiratory-induced prostate motion using wavelet decomposition of the real-time electromagnetic tracking signal.

Authors:  Yuting Lin; Tian Liu; Xiaofeng Yang; Yuenan Wang; Mohammad K Khan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-07-18       Impact factor: 7.038

10.  Automatic prostate tracking and motion assessment in volumetric modulated arc therapy with an electronic portal imaging device.

Authors:  Juan Diego Azcona; Ruijiang Li; Edward Mok; Steven Hancock; Lei Xing
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-04-19       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.